Abstract:Complex changes in the brain microenvironment following traumatic brain injury (TBI) can cause neurological impairments for which there are few efficacious therapeutic interventions. The reactivity of astrocytes is one of the keys to microenvironmental changes, such as neuroinflammation, but its role and the molecular mechanisms that underpin it remain unclear. Male C57BL/6J mice were subjected to the controlled cortical impact (CCI) to develop a TBI model. The specific ligand of AXL receptor tyrosine kinase (AXL), recombinant mouse growth arrest-specific 6 (rmGas6) was intracerebroventricularly administered, and selective AXL antagonist R428 was intraperitoneally applied at 30 min post-modeling separately. Post-TBI assessments included neurobehavioral assessments, transmission electron microscopy, immunohistochemistry, and western blotting. Real-time polymerase chain reaction (RT-PCR), siRNA transfection, and flow cytometry were performed for mechanism assessments in primary cultured astrocytes. AXL is upregulated mainly in astrocytes after TBI and promotes astrocytes switching to a phenotype that exhibits the capability of ingesting degenerated neurons or debris. As a result, this astrocytic transformation promotes the limitation of neuroinflammation and recovery of neurological dysfunction. Pharmacological inhibition of AXL in astrocytes significantly decreased astrocytic phagocytosis both in vivo and in primary astrocyte cultures, in contrast to the effect of treatment with the rmGas6. AXL activates the signal transducer and activator of the transcription 1 (STAT1) pathway thereby further upregulating ATP-binding cassette transporter 1 (ABCA1). Moreover, the supernatant from GAS6-depleted BV2 cells induced limited enhancement of astrocytic phagocytosis in vitro. Our work establishes the role of AXL in the transformation of astrocytes to a phagocytic phenotype via the AXL/STAT1/ABCA1 pathway which contributes to the separation of healthy brain tissue from injury-induced cell debris, further ameliorating neuroinflammation and neurological impairments after TBI. Collectively, our findings provide a potential therapeutic target for TBI.

A role for ErbB signaling in the induction of reactive astrogliosis

Signaling Pathways Regulating Neuron–glia Interaction and Their Implications in Alzheimer's Disease

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Reactive astrogliosis induced by TNF-α is associated with upregulated AEG-1 together with activated NF-κB pathway in vitro

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

FOXO3a Inhibits TNF‐α‐ and IL‐1β‐induced Astrocyte Proliferation:Implication for Reactive Astrogliosis

Epidermal Growth Factor Receptor Activation: an Upstream Signal for Transition of Quiescent Astrocytes into Reactive Astrocytes after Neural Injury

Reactive Astrocytes Display Pro-inflammatory Adaptability with Modulation of Notch-PI3K-AKT Signaling Pathway Under Inflammatory Stimulation

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

NEK6 is an Injury-Responsive Kinase Cooperating with STAT3 in Regulation of Reactive Astrogliosis

ER stress mediated‑autophagy contributes to neurological dysfunction in traumatic brain injury via the ATF6 UPR signaling pathway

A Neuroprotective Astrocyte State is Induced by Neuronal Signal EphB1 but Fails in ALS Models

Blocking Epidermal Growth Factor Receptor Attenuates Reactive Astrogliosis Through Inhibiting Cell Cycle Progression and Protects Against Ischemic Brain Injury in Rats.

Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination

Neurotoxic reactive astrocytes are induced by activated microglia

Activation of the Notch-1 Signaling Pathway May Be Involved in Intracerebral Hemorrhage-Induced Reactive Astrogliosis in Rats.

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury.

Interleukin-1β Induces a Reactive Astroglial Phenotype Via Deactivation of the Rho GTPase–Rock Axis

Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?

Genomic analysis of reactive astrogliosis

Reactive Astrocytes in Glial Scar Attract Olfactory Ensheathing Cells Migration by Secreted TNF-α in Spinal Cord Lesion of Rat